Renal comorbidity after solid organ and stem cell transplantation
Clajus C, Hanke N, Gottlieb J, Stadler M, Weismueller TJ, Strassburg CP, Broecker V, Bara C, Lehner F, Drube J, Kielstein JT, Schwarz A, Gueler F, Haller H, Schiffer M (2012)
Publication Type: Journal article
Publication year: 2012
Journal
Book Volume: 12
Pages Range: 1691-1699
Journal Issue: 7
DOI: 10.1111/j.1600-6143.2012.04047.x
Abstract
After transplantation of solid organs or hematopoietic stem cells, a significant acute decrease in renal function occurs in the majority of patients. Depending on the degree of kidney injury, a large number of patients develop chronic kidney disease (CKD) and some develop end-stage renal disease requiring renal replacement therapy. The incidence varies depending on the transplanted organ, but important risk factors for the development of CKD are preexisting renal disease, hepatitis C, diabetes, hypertension, age, sex, posttransplant acute kidney injury and thrombotic microangiopathy. This review article focuses on the risk factors of posttransplant chronic kidney disease after organ transplantation, considering the current literature and integrates the incidence and the associated mortality rates of acute and chronic kidney disease. Furthermore, we introduce the RECAST (REnal Comorbidity After Solid organ and hematopoietic stem cell Transplantation) registry. © Copyright 2012 The American Society of Transplantation and the American Society of Transplant Surgeons.
Authors with CRIS profile
Involved external institutions
Germany (DE)How to cite
APA:
Clajus, C., Hanke, N., Gottlieb, J., Stadler, M., Weismueller, T.J., Strassburg, C.P.,... Schiffer, M. (2012). Renal comorbidity after solid organ and stem cell transplantation. American Journal of Transplantation, 12(7), 1691-1699. https://doi.org/10.1111/j.1600-6143.2012.04047.x
MLA:
Clajus, C., et al. "Renal comorbidity after solid organ and stem cell transplantation." American Journal of Transplantation 12.7 (2012): 1691-1699.
BibTeX: Download